oleanolic acid has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epa, AP; Johnson, GV; Kottmann, RM; Kulkarni, AA; McCarthy, CE; Olsen, KC; Phipps, RP; Sime, PJ; Thatcher, TH | 1 |
| Agarwal, A; Antony, VB; Bolisetty, S; Ding, Q; Guroji, P; Hock, T; Jagirdar, R; Karki, S; Liu, RM; Oliva, O; Surolia, R; Thannickal, VJ; Zolak, JS | 1 |
2 other study(ies) available for oleanolic acid and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.
Topics: Case-Control Studies; Cell Movement; Cell Shape; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; GTP-Binding Proteins; Humans; Idiopathic Pulmonary Fibrosis; Lung; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Molecular Targeted Therapy; Oleanolic Acid; Phosphorylation; Prostaglandin D2; Protein Glutamine gamma Glutamyltransferase 2; Protein Kinase Inhibitors; Transglutaminases | 2014 |
Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury.
Topics: Administration, Inhalation; Animals; Biomarkers; Carbon Monoxide; Cell Differentiation; Cell Movement; Enzyme Induction; Epithelial Cells; Heme Oxygenase-1; Hemin; Humans; Idiopathic Pulmonary Fibrosis; Imidazoles; Lung; Lung Injury; Mice; Mice, Inbred C57BL; Myofibroblasts; Oleanolic Acid; Organometallic Compounds; Pleura; Transforming Growth Factor beta1 | 2013 |